Evaluation of Improvement in Skin and Nail Psoriasis in Bio-naïve Patients With Active Psoriatic Arthritis Treated With Golimumab: Results Through Week 52 of the GO-VIBRANT Study.
Phillip J MeaseM Elaine HusniSoumya D ChakravartyShelly KafkaDennis ParentiLilianne KimKim Hung LoElizabeth C HsiaArthur KavanaughPublished in: ACR open rheumatology (2020)
Improvements in skin and nail psoriasis symptoms with IV golimumab in patients with psoriatic arthritis were concomitant with improvements in QoL and arthritis disease activity through 1 year.